Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Industry News

Related Searches:

Filter by:

Merck, Sanofi End Animal Health JV
March 22, 2011
Merck and Sanofi-Aventis have terminated their agreement to form a new animal health joint venture by combining their animal health businesses Intervet/Schering-Plough and Merial.   Read More »
Tesaro Acquires Rights To Amgen ALK Program
March 22, 2011
Tesaro, Inc. has signed an agreement with Amgen to gain exclusive worldwide rights for the development, manufacture, commercialization of small molecule inhibitors of Anaplastic Lymphoma Kinase (ALK).   Read More »
Gerresheimer Acquires Brazilian Manufacturer
March 22, 2011
Gerresheimer AG has acquired Vedat, a Brazilian manufacturer of plastic pharmaceutical packaging products, in an effort to strengthen its pharmaceutical packaging business in South America.   Read More »
Quest To Acquire Celera Corp.
March 18, 2011
Quest Diagnostics, Inc. will acquire Celera Corp. for $671 million, providing Quest with access to genetic tests and an R&D pipeline focused on cardiovascular disease and cancer.   Read More »
Ambrilia, ZBx Enter Licensing Deal
March 18, 2011
Ambrilia has entered into an agreement granting ZBx Corp. an option to acquire exclusive worldwide rights to Ambrilia's PSP-94 reagents and related intellectual property.   Read More »
MorphoSys, Boehringer Sign Manufacturing Pact
March 16, 2011
MorphoSys AG and Boehringer Ingelheim have signed a manufacturing agreement for therapeutic antibodies covering the process development and manufacture of additional clinical material for MorphoSys’s MOR208 program and other drug candidates.   Read More »
Akrimax Launches NitroMist
March 16, 2011
Akrimax Pharmaceuticals has introduced NitroMist (Nitroglycerin Lingual Aerosol) 400mcg/spray indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.   Read More »
Almac Adds Walleting For Clinical Trial Supply
March 16, 2011
Almac has invested in two ZED automated inline wallet presses at its Craigavon and Pennsylvania facilities.   Read More »
Cytovance To Expand Bio-Manufacturing Capabilities
March 15, 2011
Cytovance Biologics has secured financing of $22.5 million from Great Point Partners, LLC to invest in the expansion its biologic manufacturing capabilities in Oklahoma City.   Read More »
Lilly Bids For J&J Animal Health Biz
March 14, 2011
Elanco, Lilly’s animal health division, has made a one-time offer to acquire the animal health business of Janssen Pharmaceutica NV, a Johnson & Johnson company.   Read More »
PROLOR Biotech Expands R&D Facility
March 14, 2011
PROLOR Biotech, Inc. is relocating its corporate office and R&D facility to a new, larger building located near its current site in the Weizmann Science Park in Nes Ziona, Israel.   Read More »
J&J Unit Signs Consent Decree For U.S. Facilities
March 11, 2011
McNeil-PPC, Inc., a Johnson & Johnson subsidiary, has finalized the terms of a Consent Decree with the FDA.   Read More »
FDA Approves Dendreon Expansion
March 11, 2011
Dendreon Corp. received approval from the FDA for the expansion of its NJ manufacturing facility, allowing the company to significantly increase the availability of Provenge.   Read More »
GNS, Biogen Idec Identify RA Drug Targets
March 11, 2011
GNS Healthcare and Biogen Idec published results from a study focused on identifying novel drug targets for the one-third of rheumatoid arthritis patients who do not respond to leading anti-TNF therapies.   Read More »
Catalent’s Schorndorf Facility Marks 50 Years
March 10, 2011
Catalent Pharma Solutions celebrates the 50th anniversary of its Schorndorf, Germany facility, which specializes in modified release technologies and clinical supply services.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: